Results 261 to 270 of about 25,149 (297)
Effects of cysteamine onPseudomonas infections in mice [PDF]
Antonie van Leeuwenhoek, 1964 A non-lethal dose of cysteamine — a radioprotective agent — when administered intraperitoneally was demonstrated to increase the susceptibility of mice to infection byPseudomonas aeruginosa. At numbers of cells (about 106) which killed 30–40 per cent of the untreated mice, the intraperitoneal treatment with 5 mg per day of cysteamine raised the ...
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Particle & Particle Systems Characterization, 2018
Sonodynamic therapy (SDT), as a newly emerging and promising modality for cancer treatment, has been extensively investigated but with limited therapeutic outcome because of the absence of highly efficient sonosensitizer.
Pan Wang +9 more
semanticscholar +1 more source
Sonodynamic therapy (SDT), as a newly emerging and promising modality for cancer treatment, has been extensively investigated but with limited therapeutic outcome because of the absence of highly efficient sonosensitizer.
Pan Wang +9 more
semanticscholar +1 more source
, 2020
Cysteamine is used as an orphan drug in the treatment of cystinosis to prevent long-term cystine accumulation in lysosomes. Dosing in cysteamine treatment is extremely important and overdose may cause some side effects.
Merve Tumur +2 more
semanticscholar +1 more source
Cysteamine is used as an orphan drug in the treatment of cystinosis to prevent long-term cystine accumulation in lysosomes. Dosing in cysteamine treatment is extremely important and overdose may cause some side effects.
Merve Tumur +2 more
semanticscholar +1 more source
ACS Applied Nano Materials, 2019
Despite the significant therapeutic use of cysteamine as drug in cystinosis, it also has some serious health issues such as idiopathic intracranial hypertension (IIH), Ehlers–Danlos syndrome, and eye related problems including blurred or loss of vision ...
Gagandeep Singh +4 more
semanticscholar +1 more source
Despite the significant therapeutic use of cysteamine as drug in cystinosis, it also has some serious health issues such as idiopathic intracranial hypertension (IIH), Ehlers–Danlos syndrome, and eye related problems including blurred or loss of vision ...
Gagandeep Singh +4 more
semanticscholar +1 more source
Steroid derivatives of cysteamine and cysteine
Canadian Journal of Chemistry, 1969A number of androstenone, estrone, and pregnenone derivatives of cysteamine have been prepared by reacting the steroid amines with ethylene monothiolcarbonate. The amides of androstenone carboxylic acid with mercaptoethylamine and cysteine have also been prepared.
Cesar Reyes-Zamora, Owen H. Wheeler
openaire +2 more sources
Journal of Molecular Recognition, 2019
In this study, a novel electroconductive interface was prepared based on Fe3O4 magnetic nanoparticle and cysteamine functionalized gold nanoparticle. The engineered interface was used as signal amplification substrate in the electrochemical analysis of ...
Fatemeh Farshchi +2 more
semanticscholar +1 more source
In this study, a novel electroconductive interface was prepared based on Fe3O4 magnetic nanoparticle and cysteamine functionalized gold nanoparticle. The engineered interface was used as signal amplification substrate in the electrochemical analysis of ...
Fatemeh Farshchi +2 more
semanticscholar +1 more source
Inhibitory effects of cysteamine on neuroendocrine function
Regulatory Peptides, 1983The action of cysteamine on anterior pituitary hormone secretion was studied in vivo using conscious, freely moving male rats and in vitro using anterior pituitary cells in monolayer culture. Administration of 500 micrograms cysteamine into the lateral cerebral ventricles of normal rats caused the complete inhibition of pulsatile GH secretion for a ...
Roger Guillemin +3 more
openaire +3 more sources
Cysteamine Therapy for Children with Nephropathic Cystinosis
New England Journal of Medicine, 1987We treated 93 children with nephropathic cystinosis with oral cysteamine (mean dose, 51.3 mg per kilogram of body weight per day) for up to 73 months. This agent is known to be effective in depleting cells of cystine. In our study, the mean cystine depletion from leukocytes was 82 percent.
Joseph D. Schulman +29 more
openaire +3 more sources
Efficacy of topical cysteamine in nephropathic cystinosis
British Journal of Ophthalmology, 2017The aim of this study is to evaluate the efficacy of topical cysteamine 0.55% eye drops in the treatment of corneal cystine crystal deposits in patients with nephropathic cystinosis.Thirty-two patients with nephropathic cystinosis were prospectively included in the study.
Igor Kozak +4 more
openaire +3 more sources